Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 23, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

127 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6919

Caliway Biopharmaceuticals
NT$538.004.9%176.3%NT$75.0bNT$707.50PS1500.8xE182.1%n/a

6446

PharmaEssentia
NT$569.00-3.7%58.7%NT$189.1bNT$853.50PE102.4xE92.0%n/a

6589

EirGenix
NT$88.60-0.1%-14.4%NT$27.1bNT$120.33PS23.1xE38.2%n/a

4743

Oneness Biotech
NT$103.50-3.7%-47.0%NT$49.4bNT$234.00PS440.5xE36.8%0%

6472

Bora Pharmaceuticals
NT$788.002.3%23.7%NT$81.0bNT$963.00PE20.8xE22.7%1.5%

1795

Lotus Pharmaceutical
NT$281.501.4%12.6%NT$74.7bNT$398.80PE17.2xE22.3%1.7%

6535

Lumosa Therapeutics
NT$353.004.3%463.0%NT$58.2bNT$244.00PS1539.6xE20.2%n/a

4147

TaiMed Biologics
NT$79.90-0.7%-4.9%NT$21.8bNT$127.33PS35xE-0.07%n/a

4162

PharmaEngine
NT$93.80-6.1%-9.8%NT$13.5bNT$120.00PE36.4xE-26.3%1.6%

6610

TWi Biotechnology
NT$13.40-0.4%-12.1%NT$1.2bn/aPB4.8xn/an/a

1720

Standard Chemical & Pharmaceutical
NT$64.401.7%1.3%NT$11.5bNT$80.00PE13.6xn/a4.2%

4170

Vectorite Biomedical
NT$15.00-0.3%n/aNT$656.6mn/aPS12.3xn/an/a

6580

TaiRx
NT$29.655.7%5.5%NT$3.3bn/aPS616.3xn/an/a

6814

Lukas Biomedical
NT$29.801.0%2.4%NT$1.2bn/aPS5.8xn/an/a

4111

Chi Sheng Pharma & Biotech
NT$26.800.8%1.5%NT$1.5bn/aPE21.4xn/a3.7%

6875

Pharmosa Biopharm
NT$56.90-8.5%-35.3%NT$7.3bn/aPS145.3xn/an/a

6973

U-Neuron Biomedical
NT$39.35-1.9%-4.8%NT$1.2bn/an/an/an/a

6677

Anxo Pharmaceutical
NT$27.95-3.5%-39.6%NT$1.6bn/aPS1.7xn/a1.4%

6547

Medigen Vaccine Biologics
NT$38.301.6%-44.3%NT$12.6bn/aPS19.4xn/an/a

1762

Chunghwa Chemical Synthesis & Biotech
NT$38.30-0.4%-33.9%NT$3.0bn/aPE30.4xn/a2.1%

8279

Syngen BiotechLtd
NT$131.000.8%-14.9%NT$3.6bn/aPE14.9xn/a3.8%

6885

BRIM Biotechnology
NT$41.90-2.9%-44.4%NT$4.9bn/aPS43694.5xn/an/a

4160

Genetics Generation Advancement
NT$84.806.0%119.4%NT$2.3bn/aPE38.7xn/a0.6%

6748

ACRO Biomedical
NT$25.707.3%-34.3%NT$1.6bn/an/an/an/a
Page 1 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.